SZETO, Cheuk Chun

Name :

Szeto, Cheuk Chun 司徒卓俊

Title :

Professor of Medicine and Therapeutics

Home Department :

Medicine and Therapeutics

Email :

ccszeto@cuhk.edu.hk

Phone Number:

(852) 3505 3101

Fax Number:

(852) 2637 3852

Website:

www.mect.cuhk.edu.hk/people/ccszeto.html

Biography:

CC Szeto is currently a Professor of Department of Medicine & Therapeutics, The Chinese University of Hong Kong, and a Honorary Consultant Physician of Prince of Wales Hospital. He is also currently the chairman of the Best Practice Recommendations Committee of the Asian Pacific Society of Nephrology, chairman of the Examination Subcommittee of the Medical Council of Hong Kong, the Chairman of the Nephrology Specialty Board and the secretary of Credentialing Committee, both under the Hong Kong College of Physician.

Specialised Research Area(s):

Biomarker and translational research in kidney diseases.
Peritoneal dialysis, especially peritoneal dialysis related infections, vascular disease and circulating bacterial fragment in renal failure.
Glomerular diseases, especially urinary biomarkers and treatment of glomerulonephritis.

Selected Publications:

1. Szeto CC, Sugano K, Wang JG, Fujimoto K, Whittle S, Modi GK, Chen CH, Park JB, Tam LS, Vareesangthip K, Tsoi KKF, Chan FKL. Non-steroidal anti-inflammatory Drug (NSAID) Therapy in Patients with hypertension, cardiovascular, Renal or Gastrointestinal comorbidities: Joint APAGE/APLAR/APSDE/APSH/APSN/PoA Recommendations. Gut. 2020;69(4):617-629. doi:10.1136/gutjnl-2019-319300.

2. Szeto CC, Li PKT. Peritoneal Dialysis–Associated Peritonitis. Clinical Journal of the American Society of Nephrology. 2019;14(7):1100-1105. doi:10.2215/cjn.14631218.

3. Szeto CC, Lo WK, Li PK. Clinical Practice Guidelines for the Provision of Renal Service in Hong Kong: Peritoneal Dialysis. Nephrology. 2019;24(S1):27-40. doi:10.1111/nep.13505.

4. Szeto CC, McIntyre CW, Li PKT. Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. Journal of the American Society of Nephrology. 2018;29(6):1601-1608. doi:10.1681/asn.2018010068.

5. Szeto CC, Li PKT, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. ISPD Catheter-Related Infection Recommendations: 2017 Update. Peritoneal Dialysis International. 2017;37(2):141-154. doi:10.3747/pdi.2016.00120.

6. Szeto CC, Kwan BCH, Chow KM, Cheng PMS, Kwong VWK, Choy ASM, Law MC, Leung CB, Li PKT. The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition – a Randomized Control Trial. PLOS ONE. 2015;10(10):e0141425. doi:10.1371/journal.pone.0141425.

7. Szeto CC, Kwan BCH, Chow KM, Kwok JSS, Lai KB, Cheng PMS, Pang WF, Ng JKC, Chan MHM, Lit LCW, Leung CB, Li PKT. Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients. PLOS ONE. 2015;10(5):e0125162. doi:10.1371/journal.pone.0125162..

8. Szeto CC, Lai FMM, Chow KM, Kwan BCH, Kwong VWK, Leung CB, Li PKT. Long-term Outcome of Biopsy-Proven Minimal Change Nephropathy in Chinese Adults. American Journal of Kidney Diseases. 2015;65(5):710-718. doi:10.1053/j.ajkd.2014.09.022.

9. Szeto CC, Li PKT. MicroRNAs in IgA Nephropathy. Nature Reviews Nephrology. 2014;10(5):249-256. doi:10.1038/nrneph.2014.50

10. Szeto CC, Kwan BCH, Chow KM, Leung CB, Cheng MS, Law MC, Li PKT. Metabolic Syndrome in Peritoneal Dialysis Patients: Choice of Diagnostic Criteria and Prognostic Implications. Clinical Journal of the American Society of Nephrology. 2014;9(4):779-787. doi:10.2215/cjn.06620613.